QA: Sage Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001597553_2020_Sage_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001597553, Sage Therapeutics Inc

  xvar xval
0 AssetsCurrent 1,035,093,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 9,126,000
3 remainder_Assets 39,931,000
4 LiabilitiesCurrent 112,128,000
5 LiabilitiesNoncurrent 27,367,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 345,777,000
9 ResearchAndDevelopmentExpense 368,815,000
10 remainder_Expenses 400,000
11 remainder_Revenues 6,868,000
12 remainder_NetIncome 27,886,000
13 remainder_ComprehensiveNetIncome 1,810,000
  yvar yval
0 Assets 1,084,150,000
1 Liabilities 139,495,000
2 Expenses 714,992,000
3 Revenues 6,868,000
4 StockholdersEquity 944,655,000
5 NetIncome -680,238,000
6 ComprehensiveNetIncome -679,333,000
7 BaseVar 987,600,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.26
9 EconomicCapitalRatio 3.19

Edgar->Model Mapping

Feature Distribution

Change over Time